Treatment(s) already received-Lumpectomy Posts on Medivizor
Navigation Menu

Treatment(s) already received-Lumpectomy Posts on Medivizor

Local disease recurrence in patients with HER2-positive breast cancer: an evaluation of treatment effectiveness

Posted by on Apr 30, 2019 in Breast cancer | 0 comments

In a nutshell This study investigated if trastuzumab (Herceptin)/paclitaxel (Taxol) reduces the risk of local-regional recurrence (LRR) in patients with HER2-positive breast cancer (BC).  They found that this treatment reduced LRR risk in HER2-positive patients.  Some background Breast cancer (BC) is one of the most common cancers....

Read More

Denosumab treatment in HR+ breast cancer

Posted by on Apr 30, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if adding the medication denosumab (Prolia, Xgeva) to cancer treatment for women with breast cancer reduces the risk of bone fractures. The study found that the patients treated with denosumab survived better, but there was no significant difference in the number of bone fractures. Some background Breast...

Read More

Breast Reconstruction Following Breast Cancer Treatment

Posted by on Oct 5, 2018 in Breast cancer | 0 comments

In a nutshell This is a 2018 update on breast reconstruction following breast cancer treatment. It has been found that nearly 40% of women who undergo a mastectomy will have a breast reconstruction. Some background It was estimated that in 2017 106000 reconstructive breast surgeries were done. The main reason for this is to do with the psychological...

Read More

A comparison of how FEC120 treatment vs EC-docetaxel treatment affect survival in patients with node-positive primary breast cancer

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study compared the side effects and outcome of two drug regimens in women with high-risk node-positive breast cancer (BC). Both treatment regimens were found to have similar survival outcomes. Some background Standard treatment in node positive BC (cancer that has spread to the lymph nodes) consists of two categories of...

Read More

Can we predict recurrence of ductal carcinoma in situ after breast conserving surgery?

Posted by on Jul 25, 2016 in Breast cancer | 1 comment

In a nutshell Patients with ductal carcinoma in situ (DCIS) who undergo breast conserving surgery (BCS) are at risk of cancer recurrence. This study aimed to identify risk factors which could predict the likelihood of recurrence. It was found that a low tumor grade, presence of cancerous cells in the area directly around the tumor, the presence of a...

Read More

The influence of infection on breast cancer recurrence following breast reconstruction

Posted by on Mar 21, 2016 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the influence of possible infections following breast reconstruction on the risks of breast cancer recurrence. This study showed that post-operative complications or infections had a significant impact on the rates of breast cancer recurrence. Some background Breast reconstruction surgery is a procedure...

Read More

Breast cancer; what are the risks of cancer returning following surgery?

Posted by on Jun 24, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the overall risks of breast cancer recurrence (return of the cancer) following two types of breast cancer surgery. Some background Breast cancer treatments may include surgery; a mastectomy is the removal of the entire breast while breast-conserving surgery is the removal of the breast cancer but not the...

Read More

Cancer sub-types; what are the characteristics?

Posted by on Jun 24, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to distinguish whether the characteristics of breast cancer could depend on the focality of the tumor. Some background Breast cancer can be characterized as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found (focality); unifocal...

Read More